remember this has been SERIOUSLY undervalued for a very, very long time so what we have got used to as normal has been pretty unreasonable.
We have had a mMarket cap of cash in hand value for a company that has multiple compounds with great preclinical results for very large potential markets now moving into phase 2 with a market with no competition is a big deal.
Ann: Pause in Trading, page-10
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $8.021K | 2.111M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 23398919 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 132896552 | 36 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |